DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced the webcast of an Impella® 2.5 procedure performed on an 85-year-old male with multi-vessel disease at Mount Sinai Medical Center, now available and archived on the Abiomed website (www.abiomed.com).
